According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Plant-Derived Recombinant Human Serum Albumin Market

Plant-Derived Recombinant Human Serum Albumin is a highly purified animal-, virus-, and prion-free product developed as an alternative to human serum albumin (HSA).

The global Plant-Derived Recombinant Human Serum Albumin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Plant-Derived Recombinant Human Serum Albumin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plant-Derived Recombinant Human Serum Albumin.

Report Scope

The Plant-Derived Recombinant Human Serum Albumin market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plant-Derived Recombinant Human Serum Albumin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Plant-Derived Recombinant Human Serum Albumin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Plant-Derived Recombinant Human Serum Albumin Market Report

Report Metric	Details
Report Name	Plant-Derived Recombinant Human Serum Albumin Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	OsrHSA ScrHSA
Segment by Application	Scientific Research Pharmaceutical Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Albumedix, Merck, Ventria (InVitria), Novozymes Biopharma, CSL Limited, LGC Group, Bipha Ayurveda (IHI Corporation), Wuhan Healthgen Biotechnology Corp., Takeda Pharmaceutical Company Limited, NCPC, Oryzogen, HiMedia, Grifols, Aspira Chemical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Plant-Derived Recombinant Human Serum Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Plant-Derived Recombinant Human Serum Albumin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Plant-Derived Recombinant Human Serum Albumin Market report?

Ans: The main players in the Plant-Derived Recombinant Human Serum Albumin Market are Albumedix, Merck, Ventria (InVitria), Novozymes Biopharma, CSL Limited, LGC Group, Bipha Ayurveda (IHI Corporation), Wuhan Healthgen Biotechnology Corp., Takeda Pharmaceutical Company Limited, NCPC, Oryzogen, HiMedia, Grifols, Aspira Chemical

What are the Application segmentation covered in the Plant-Derived Recombinant Human Serum Albumin Market report?

Ans: The Applications covered in the Plant-Derived Recombinant Human Serum Albumin Market report are Scientific Research, Pharmaceutical, Others

What are the Type segmentation covered in the Plant-Derived Recombinant Human Serum Albumin Market report?

Ans: The Types covered in the Plant-Derived Recombinant Human Serum Albumin Market report are OsrHSA, ScrHSA

1 Plant-Derived Recombinant Human Serum Albumin Market Overview

1.1 Product Overview and Scope of Plant-Derived Recombinant Human Serum Albumin

1.2 Plant-Derived Recombinant Human Serum Albumin Segment by Type

1.2.1 Global Plant-Derived Recombinant Human Serum Albumin Market Value Comparison by Type (2024-2030)

1.2.2 OsrHSA

1.2.3 ScrHSA

1.3 Plant-Derived Recombinant Human Serum Albumin Segment by Application

1.3.1 Global Plant-Derived Recombinant Human Serum Albumin Market Value by Application: (2024-2030)

1.3.2 Scientific Research

1.3.3 Pharmaceutical

1.3.4 Others

1.4 Global Plant-Derived Recombinant Human Serum Albumin Market Size Estimates and Forecasts

1.4.1 Global Plant-Derived Recombinant Human Serum Albumin Revenue 2019-2030

1.4.2 Global Plant-Derived Recombinant Human Serum Albumin Sales 2019-2030

1.4.3 Global Plant-Derived Recombinant Human Serum Albumin Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Plant-Derived Recombinant Human Serum Albumin Market Competition by Manufacturers

2.1 Global Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Manufacturers (2019-2024)

2.2 Global Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Plant-Derived Recombinant Human Serum Albumin Average Price by Manufacturers (2019-2024)

2.4 Global Plant-Derived Recombinant Human Serum Albumin Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Plant-Derived Recombinant Human Serum Albumin, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Plant-Derived Recombinant Human Serum Albumin, Product Type & Application

2.7 Plant-Derived Recombinant Human Serum Albumin Market Competitive Situation and Trends

2.7.1 Plant-Derived Recombinant Human Serum Albumin Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Plant-Derived Recombinant Human Serum Albumin Players Market Share by Revenue

2.7.3 Global Plant-Derived Recombinant Human Serum Albumin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Plant-Derived Recombinant Human Serum Albumin Retrospective Market Scenario by Region

3.1 Global Plant-Derived Recombinant Human Serum Albumin Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Plant-Derived Recombinant Human Serum Albumin Global Plant-Derived Recombinant Human Serum Albumin Sales by Region: 2019-2030

3.2.1 Global Plant-Derived Recombinant Human Serum Albumin Sales by Region: 2019-2024

3.2.2 Global Plant-Derived Recombinant Human Serum Albumin Sales by Region: 2025-2030

3.3 Global Plant-Derived Recombinant Human Serum Albumin Global Plant-Derived Recombinant Human Serum Albumin Revenue by Region: 2019-2030

3.3.1 Global Plant-Derived Recombinant Human Serum Albumin Revenue by Region: 2019-2024

3.3.2 Global Plant-Derived Recombinant Human Serum Albumin Revenue by Region: 2025-2030

3.4 North America Plant-Derived Recombinant Human Serum Albumin Market Facts & Figures by Country

3.4.1 North America Plant-Derived Recombinant Human Serum Albumin Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Plant-Derived Recombinant Human Serum Albumin Sales by Country (2019-2030)

3.4.3 North America Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Plant-Derived Recombinant Human Serum Albumin Market Facts & Figures by Country

3.5.1 Europe Plant-Derived Recombinant Human Serum Albumin Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Plant-Derived Recombinant Human Serum Albumin Sales by Country (2019-2030)

3.5.3 Europe Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Plant-Derived Recombinant Human Serum Albumin Market Facts & Figures by Country

3.6.1 Asia Pacific Plant-Derived Recombinant Human Serum Albumin Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Plant-Derived Recombinant Human Serum Albumin Sales by Country (2019-2030)

3.6.3 Asia Pacific Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Plant-Derived Recombinant Human Serum Albumin Market Facts & Figures by Country

3.7.1 Latin America Plant-Derived Recombinant Human Serum Albumin Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Plant-Derived Recombinant Human Serum Albumin Sales by Country (2019-2030)

3.7.3 Latin America Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Plant-Derived Recombinant Human Serum Albumin Market Facts & Figures by Country

3.8.1 Middle East and Africa Plant-Derived Recombinant Human Serum Albumin Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Plant-Derived Recombinant Human Serum Albumin Sales by Country (2019-2030)

3.8.3 Middle East and Africa Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Plant-Derived Recombinant Human Serum Albumin Sales by Type (2019-2030)

4.1.1 Global Plant-Derived Recombinant Human Serum Albumin Sales by Type (2019-2024)

4.1.2 Global Plant-Derived Recombinant Human Serum Albumin Sales by Type (2025-2030)

4.1.3 Global Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Type (2019-2030)

4.2 Global Plant-Derived Recombinant Human Serum Albumin Revenue by Type (2019-2030)

4.2.1 Global Plant-Derived Recombinant Human Serum Albumin Revenue by Type (2019-2024)

4.2.2 Global Plant-Derived Recombinant Human Serum Albumin Revenue by Type (2025-2030)

4.2.3 Global Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Type (2019-2030)

4.3 Global Plant-Derived Recombinant Human Serum Albumin Price by Type (2019-2030)

5 Segment by Application

5.1 Global Plant-Derived Recombinant Human Serum Albumin Sales by Application (2019-2030)

5.1.1 Global Plant-Derived Recombinant Human Serum Albumin Sales by Application (2019-2024)

5.1.2 Global Plant-Derived Recombinant Human Serum Albumin Sales by Application (2025-2030)

5.1.3 Global Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Application (2019-2030)

5.2 Global Plant-Derived Recombinant Human Serum Albumin Revenue by Application (2019-2030)

5.2.1 Global Plant-Derived Recombinant Human Serum Albumin Revenue by Application (2019-2024)

5.2.2 Global Plant-Derived Recombinant Human Serum Albumin Revenue by Application (2025-2030)

5.2.3 Global Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Application (2019-2030)

5.3 Global Plant-Derived Recombinant Human Serum Albumin Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Albumedix

6.1.1 Albumedix Corporation Information

6.1.2 Albumedix Description and Business Overview

6.1.3 Albumedix Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Albumedix Plant-Derived Recombinant Human Serum Albumin Product Portfolio

6.1.5 Albumedix Recent Developments/Updates

6.2 Merck

6.2.1 Merck Corporation Information

6.2.2 Merck Description and Business Overview

6.2.3 Merck Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Merck Plant-Derived Recombinant Human Serum Albumin Product Portfolio

6.2.5 Merck Recent Developments/Updates

6.3 Ventria (InVitria)

6.3.1 Ventria (InVitria) Corporation Information

6.3.2 Ventria (InVitria) Description and Business Overview

6.3.3 Ventria (InVitria) Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Ventria (InVitria) Plant-Derived Recombinant Human Serum Albumin Product Portfolio

6.3.5 Ventria (InVitria) Recent Developments/Updates

6.4 Novozymes Biopharma

6.4.1 Novozymes Biopharma Corporation Information

6.4.2 Novozymes Biopharma Description and Business Overview

6.4.3 Novozymes Biopharma Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Novozymes Biopharma Plant-Derived Recombinant Human Serum Albumin Product Portfolio

6.4.5 Novozymes Biopharma Recent Developments/Updates

6.5 CSL Limited

6.5.1 CSL Limited Corporation Information

6.5.2 CSL Limited Description and Business Overview

6.5.3 CSL Limited Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)

6.5.4 CSL Limited Plant-Derived Recombinant Human Serum Albumin Product Portfolio

6.5.5 CSL Limited Recent Developments/Updates

6.6 LGC Group

6.6.1 LGC Group Corporation Information

6.6.2 LGC Group Description and Business Overview

6.6.3 LGC Group Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)

6.6.4 LGC Group Plant-Derived Recombinant Human Serum Albumin Product Portfolio

6.6.5 LGC Group Recent Developments/Updates

6.7 Bipha Ayurveda (IHI Corporation)

6.6.1 Bipha Ayurveda (IHI Corporation) Corporation Information

6.6.2 Bipha Ayurveda (IHI Corporation) Description and Business Overview

6.6.3 Bipha Ayurveda (IHI Corporation) Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Bipha Ayurveda (IHI Corporation) Plant-Derived Recombinant Human Serum Albumin Product Portfolio

6.7.5 Bipha Ayurveda (IHI Corporation) Recent Developments/Updates

6.8 Wuhan Healthgen Biotechnology Corp.

6.8.1 Wuhan Healthgen Biotechnology Corp. Corporation Information

6.8.2 Wuhan Healthgen Biotechnology Corp. Description and Business Overview

6.8.3 Wuhan Healthgen Biotechnology Corp. Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Wuhan Healthgen Biotechnology Corp. Plant-Derived Recombinant Human Serum Albumin Product Portfolio

6.8.5 Wuhan Healthgen Biotechnology Corp. Recent Developments/Updates

6.9 Takeda Pharmaceutical Company Limited

6.9.1 Takeda Pharmaceutical Company Limited Corporation Information

6.9.2 Takeda Pharmaceutical Company Limited Description and Business Overview

6.9.3 Takeda Pharmaceutical Company Limited Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Takeda Pharmaceutical Company Limited Plant-Derived Recombinant Human Serum Albumin Product Portfolio

6.9.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates

6.10 NCPC

6.10.1 NCPC Corporation Information

6.10.2 NCPC Description and Business Overview

6.10.3 NCPC Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)

6.10.4 NCPC Plant-Derived Recombinant Human Serum Albumin Product Portfolio

6.10.5 NCPC Recent Developments/Updates

6.11 Oryzogen

6.11.1 Oryzogen Corporation Information

6.11.2 Oryzogen Plant-Derived Recombinant Human Serum Albumin Description and Business Overview

6.11.3 Oryzogen Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Oryzogen Plant-Derived Recombinant Human Serum Albumin Product Portfolio

6.11.5 Oryzogen Recent Developments/Updates

6.12 HiMedia

6.12.1 HiMedia Corporation Information

6.12.2 HiMedia Plant-Derived Recombinant Human Serum Albumin Description and Business Overview

6.12.3 HiMedia Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)

6.12.4 HiMedia Plant-Derived Recombinant Human Serum Albumin Product Portfolio

6.12.5 HiMedia Recent Developments/Updates

6.13 Grifols

6.13.1 Grifols Corporation Information

6.13.2 Grifols Plant-Derived Recombinant Human Serum Albumin Description and Business Overview

6.13.3 Grifols Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Grifols Plant-Derived Recombinant Human Serum Albumin Product Portfolio

6.13.5 Grifols Recent Developments/Updates

6.14 Aspira Chemical

6.14.1 Aspira Chemical Corporation Information

6.14.2 Aspira Chemical Plant-Derived Recombinant Human Serum Albumin Description and Business Overview

6.14.3 Aspira Chemical Plant-Derived Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Aspira Chemical Plant-Derived Recombinant Human Serum Albumin Product Portfolio

6.14.5 Aspira Chemical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Plant-Derived Recombinant Human Serum Albumin Industry Chain Analysis

7.2 Plant-Derived Recombinant Human Serum Albumin Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Plant-Derived Recombinant Human Serum Albumin Production Mode & Process

7.4 Plant-Derived Recombinant Human Serum Albumin Sales and Marketing

7.4.1 Plant-Derived Recombinant Human Serum Albumin Sales Channels

7.4.2 Plant-Derived Recombinant Human Serum Albumin Distributors

7.5 Plant-Derived Recombinant Human Serum Albumin Customers

8 Plant-Derived Recombinant Human Serum Albumin Market Dynamics

8.1 Plant-Derived Recombinant Human Serum Albumin Industry Trends

8.2 Plant-Derived Recombinant Human Serum Albumin Market Drivers

8.3 Plant-Derived Recombinant Human Serum Albumin Market Challenges

8.4 Plant-Derived Recombinant Human Serum Albumin Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Wuhan Healthgen Biotechnology Corp

Takeda Pharmaceutical Company Limited

Bipha Ayurveda (IHI Corporation)

Aspira Chemical

List of Tables

Table 1. Global Plant-Derived Recombinant Human Serum Albumin Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Plant-Derived Recombinant Human Serum Albumin Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Plant-Derived Recombinant Human Serum Albumin Market Competitive Situation by Manufacturers in 2023

Table 4. Global Plant-Derived Recombinant Human Serum Albumin Sales (Units) of Key Manufacturers (2019-2024)

Table 5. Global Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Plant-Derived Recombinant Human Serum Albumin Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Plant-Derived Recombinant Human Serum Albumin Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Plant-Derived Recombinant Human Serum Albumin Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Plant-Derived Recombinant Human Serum Albumin, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Plant-Derived Recombinant Human Serum Albumin, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Plant-Derived Recombinant Human Serum Albumin, Product Type & Application

Table 12. Global Key Manufacturers of Plant-Derived Recombinant Human Serum Albumin, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Plant-Derived Recombinant Human Serum Albumin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plant-Derived Recombinant Human Serum Albumin as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Plant-Derived Recombinant Human Serum Albumin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Plant-Derived Recombinant Human Serum Albumin Sales by Region (2019-2024) & (Units)

Table 18. Global Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Region (2019-2024)

Table 19. Global Plant-Derived Recombinant Human Serum Albumin Sales by Region (2025-2030) & (Units)

Table 20. Global Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Region (2025-2030)

Table 21. Global Plant-Derived Recombinant Human Serum Albumin Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Region (2019-2024)

Table 23. Global Plant-Derived Recombinant Human Serum Albumin Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Region (2025-2030)

Table 25. North America Plant-Derived Recombinant Human Serum Albumin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Plant-Derived Recombinant Human Serum Albumin Sales by Country (2019-2024) & (Units)

Table 27. North America Plant-Derived Recombinant Human Serum Albumin Sales by Country (2025-2030) & (Units)

Table 28. North America Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Plant-Derived Recombinant Human Serum Albumin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Plant-Derived Recombinant Human Serum Albumin Sales by Country (2019-2024) & (Units)

Table 32. Europe Plant-Derived Recombinant Human Serum Albumin Sales by Country (2025-2030) & (Units)

Table 33. Europe Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Plant-Derived Recombinant Human Serum Albumin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Plant-Derived Recombinant Human Serum Albumin Sales by Region (2019-2024) & (Units)

Table 37. Asia Pacific Plant-Derived Recombinant Human Serum Albumin Sales by Region (2025-2030) & (Units)

Table 38. Asia Pacific Plant-Derived Recombinant Human Serum Albumin Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Plant-Derived Recombinant Human Serum Albumin Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Plant-Derived Recombinant Human Serum Albumin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Plant-Derived Recombinant Human Serum Albumin Sales by Country (2019-2024) & (Units)

Table 42. Latin America Plant-Derived Recombinant Human Serum Albumin Sales by Country (2025-2030) & (Units)

Table 43. Latin America Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Plant-Derived Recombinant Human Serum Albumin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Plant-Derived Recombinant Human Serum Albumin Sales by Country (2019-2024) & (Units)

Table 47. Middle East & Africa Plant-Derived Recombinant Human Serum Albumin Sales by Country (2025-2030) & (Units)

Table 48. Middle East & Africa Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Plant-Derived Recombinant Human Serum Albumin Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Plant-Derived Recombinant Human Serum Albumin Sales (Units) by Type (2019-2024)

Table 51. Global Plant-Derived Recombinant Human Serum Albumin Sales (Units) by Type (2025-2030)

Table 52. Global Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Type (2019-2024)

Table 53. Global Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Type (2025-2030)

Table 54. Global Plant-Derived Recombinant Human Serum Albumin Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Plant-Derived Recombinant Human Serum Albumin Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Type (2019-2024)

Table 57. Global Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Type (2025-2030)

Table 58. Global Plant-Derived Recombinant Human Serum Albumin Price (US$/Unit) by Type (2019-2024)

Table 59. Global Plant-Derived Recombinant Human Serum Albumin Price (US$/Unit) by Type (2025-2030)

Table 60. Global Plant-Derived Recombinant Human Serum Albumin Sales (Units) by Application (2019-2024)

Table 61. Global Plant-Derived Recombinant Human Serum Albumin Sales (Units) by Application (2025-2030)

Table 62. Global Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Application (2019-2024)

Table 63. Global Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Application (2025-2030)

Table 64. Global Plant-Derived Recombinant Human Serum Albumin Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Plant-Derived Recombinant Human Serum Albumin Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Application (2019-2024)

Table 67. Global Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Application (2025-2030)

Table 68. Global Plant-Derived Recombinant Human Serum Albumin Price (US$/Unit) by Application (2019-2024)

Table 69. Global Plant-Derived Recombinant Human Serum Albumin Price (US$/Unit) by Application (2025-2030)

Table 70. Albumedix Corporation Information

Table 71. Albumedix Description and Business Overview

Table 72. Albumedix Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Albumedix Plant-Derived Recombinant Human Serum Albumin Product

Table 74. Albumedix Recent Developments/Updates

Table 75. Merck Corporation Information

Table 76. Merck Description and Business Overview

Table 77. Merck Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Merck Plant-Derived Recombinant Human Serum Albumin Product

Table 79. Merck Recent Developments/Updates

Table 80. Ventria (InVitria) Corporation Information

Table 81. Ventria (InVitria) Description and Business Overview

Table 82. Ventria (InVitria) Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Ventria (InVitria) Plant-Derived Recombinant Human Serum Albumin Product

Table 84. Ventria (InVitria) Recent Developments/Updates

Table 85. Novozymes Biopharma Corporation Information

Table 86. Novozymes Biopharma Description and Business Overview

Table 87. Novozymes Biopharma Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Novozymes Biopharma Plant-Derived Recombinant Human Serum Albumin Product

Table 89. Novozymes Biopharma Recent Developments/Updates

Table 90. CSL Limited Corporation Information

Table 91. CSL Limited Description and Business Overview

Table 92. CSL Limited Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. CSL Limited Plant-Derived Recombinant Human Serum Albumin Product

Table 94. CSL Limited Recent Developments/Updates

Table 95. LGC Group Corporation Information

Table 96. LGC Group Description and Business Overview

Table 97. LGC Group Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. LGC Group Plant-Derived Recombinant Human Serum Albumin Product

Table 99. LGC Group Recent Developments/Updates

Table 100. Bipha Ayurveda (IHI Corporation) Corporation Information

Table 101. Bipha Ayurveda (IHI Corporation) Description and Business Overview

Table 102. Bipha Ayurveda (IHI Corporation) Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Bipha Ayurveda (IHI Corporation) Plant-Derived Recombinant Human Serum Albumin Product

Table 104. Bipha Ayurveda (IHI Corporation) Recent Developments/Updates

Table 105. Wuhan Healthgen Biotechnology Corp. Corporation Information

Table 106. Wuhan Healthgen Biotechnology Corp. Description and Business Overview

Table 107. Wuhan Healthgen Biotechnology Corp. Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Wuhan Healthgen Biotechnology Corp. Plant-Derived Recombinant Human Serum Albumin Product

Table 109. Wuhan Healthgen Biotechnology Corp. Recent Developments/Updates

Table 110. Takeda Pharmaceutical Company Limited Corporation Information

Table 111. Takeda Pharmaceutical Company Limited Description and Business Overview

Table 112. Takeda Pharmaceutical Company Limited Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Takeda Pharmaceutical Company Limited Plant-Derived Recombinant Human Serum Albumin Product

Table 114. Takeda Pharmaceutical Company Limited Recent Developments/Updates

Table 115. NCPC Corporation Information

Table 116. NCPC Description and Business Overview

Table 117. NCPC Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. NCPC Plant-Derived Recombinant Human Serum Albumin Product

Table 119. NCPC Recent Developments/Updates

Table 120. Oryzogen Corporation Information

Table 121. Oryzogen Description and Business Overview

Table 122. Oryzogen Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Oryzogen Plant-Derived Recombinant Human Serum Albumin Product

Table 124. Oryzogen Recent Developments/Updates

Table 125. HiMedia Corporation Information

Table 126. HiMedia Description and Business Overview

Table 127. HiMedia Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. HiMedia Plant-Derived Recombinant Human Serum Albumin Product

Table 129. HiMedia Recent Developments/Updates

Table 130. Grifols Corporation Information

Table 131. Grifols Description and Business Overview

Table 132. Grifols Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Grifols Plant-Derived Recombinant Human Serum Albumin Product

Table 134. Grifols Recent Developments/Updates

Table 135. Aspira Chemical Corporation Information

Table 136. Aspira Chemical Description and Business Overview

Table 137. Aspira Chemical Plant-Derived Recombinant Human Serum Albumin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. Aspira Chemical Plant-Derived Recombinant Human Serum Albumin Product

Table 139. Aspira Chemical Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Plant-Derived Recombinant Human Serum Albumin Distributors List

Table 143. Plant-Derived Recombinant Human Serum Albumin Customers List

Table 144. Plant-Derived Recombinant Human Serum Albumin Market Trends

Table 145. Plant-Derived Recombinant Human Serum Albumin Market Drivers

Table 146. Plant-Derived Recombinant Human Serum Albumin Market Challenges

Table 147. Plant-Derived Recombinant Human Serum Albumin Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Plant-Derived Recombinant Human Serum Albumin

Figure 2. Global Plant-Derived Recombinant Human Serum Albumin Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Plant-Derived Recombinant Human Serum Albumin Market Share by Type in 2023 & 2030

Figure 4. OsrHSA Product Picture

Figure 5. ScrHSA Product Picture

Figure 6. Global Plant-Derived Recombinant Human Serum Albumin Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Plant-Derived Recombinant Human Serum Albumin Market Share by Application in 2023 & 2030

Figure 8. Scientific Research

Figure 9. Pharmaceutical

Figure 10. Others

Figure 11. Global Plant-Derived Recombinant Human Serum Albumin Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Plant-Derived Recombinant Human Serum Albumin Market Size (2019-2030) & (US$ Million)

Figure 13. Global Plant-Derived Recombinant Human Serum Albumin Sales (2019-2030) & (Units)

Figure 14. Global Plant-Derived Recombinant Human Serum Albumin Average Price (US$/Unit) & (2019-2030)

Figure 15. Plant-Derived Recombinant Human Serum Albumin Report Years Considered

Figure 16. Plant-Derived Recombinant Human Serum Albumin Sales Share by Manufacturers in 2023

Figure 17. Global Plant-Derived Recombinant Human Serum Albumin Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Plant-Derived Recombinant Human Serum Albumin Players: Market Share by Revenue in 2023

Figure 19. Plant-Derived Recombinant Human Serum Albumin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Plant-Derived Recombinant Human Serum Albumin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Country (2019-2030)

Figure 22. North America Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Country (2019-2030)

Figure 23. United States Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Country (2019-2030)

Figure 26. Europe Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Country (2019-2030)

Figure 27. Germany Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Region (2019-2030)

Figure 34. China Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Country (2019-2030)

Figure 42. Latin America Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Country (2019-2030)

Figure 43. Mexico Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Plant-Derived Recombinant Human Serum Albumin Sales Market Share by Country (2019-2030)

Figure 47. Middle East & Africa Plant-Derived Recombinant Human Serum Albumin Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Plant-Derived Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Plant-Derived Recombinant Human Serum Albumin by Type (2019-2030)

Figure 52. Global Revenue Market Share of Plant-Derived Recombinant Human Serum Albumin by Type (2019-2030)

Figure 53. Global Plant-Derived Recombinant Human Serum Albumin Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of Plant-Derived Recombinant Human Serum Albumin by Application (2019-2030)

Figure 55. Global Revenue Market Share of Plant-Derived Recombinant Human Serum Albumin by Application (2019-2030)

Figure 56. Global Plant-Derived Recombinant Human Serum Albumin Price (US$/Unit) by Application (2019-2030)

Figure 57. Plant-Derived Recombinant Human Serum Albumin Value Chain

Figure 58. Plant-Derived Recombinant Human Serum Albumin Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Distributors Profiles

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions